The authors suggested that an increased expression of CD40L on the surface of stimulated T lymphocytes may be relevant for the generation of anti-tumor immune responses via the activation of antigen-presenting cells (APC), or by direct interaction with the CD40 receptor on tumor cells. The gene discussed is CD40LG; the disease is neoplasm.